Polygenic risk scores for asthma and allergic disease associate with COVID-19 severity in 9/11 responders.
Monika A WaszczukOlga MorozovaElizabeth LhuillierAnna R DochertyAndrey A ShabalinXiaohua YangMelissa A CarrSean A P CloustonRoman KotovBenjamin J LuftPublished in: PloS one (2023)
Recently developed polygenic biomarkers for asthma, allergic disease, and COVID-19 hospitalization capture some of the individual differences in severity and clinical course of COVID-19 illness in a community population.